Adjuvant Lung Cancer Enrichment Mark Identification and Sequencing Trial (ALCHEMIST) (Alliance A151216)
This phase III ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Salvatore Del Prete, MD
Sponsor(s)Alliance for Clinical Trials in Oncology
ContactEd Hatton, RN at 203-358-8879 or [email protected]
Bennett Cancer Center
Stamford, CT 06902